In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
OPERATING ACTIVITIES | | | | | | | | |
Net income (loss) | 4.4 | 99.0 | -92.7 | -9.6 | -33.2 | -494.6 | 138.4 | 120.8 |
|
Adjustments to reconcile net income (loss) to net cash from operating activities: | | | | | | | | |
Impairment charges-net | 1.9 | 25.8 | 99.3 | 13.9 | 22.4 | 558.3 | 36.5 | 47.3 |
Depreciation and amortization | 130.5 | 150.3 | 169.2 | 181.4 | 191.4 | 363.2 | 454.0 | 474.0 |
(Benefit) provision for credit losses | -4.0 | 6.7 | 7.4 | 13.3 | 3.2 | 22.7 | 15.4 | 16.9 |
Share-based compensation | 7.1 | 8.1 | 10.9 | 8.6 | 8.4 | 12.9 | 17.3 | 17.7 |
Deferred income taxes | 12.9 | -14.7 | 21.5 | 2.7 | 21.2 | -57.6 | -36.1 | -87.0 |
Changes in uncertain tax positions | -7.3 | -3.6 | -0.9 | | | | | |
Gains from sales of property, plant and equipment | -12.4 | -148.0 | -15.1 | | | | | |
Loss on debt extinguishment | 7.1 | 3.0 | 0.8 | 32.4 | 20.1 | 96.1 | | 77.1 |
Changes in operating assets and liabilities - net of dispositions and acquisitions: | | | | | | | | |
Accounts receivable-net | -42.4 | 16.1 | 72.2 | 48.0 | -57.3 | -223.0 | -14.2 | -49.6 |
Inventories | -50.9 | 5.8 | 15.2 | 15.0 | -20.1 | -40.3 | 16.5 | -14.1 |
Prepaid expenses and other current assets | -5.1 | -5.2 | -9.2 | 0.9 | 3.7 | 2.7 | 26.3 | -10.8 |
Accounts payable | 79.1 | 3.5 | -96.4 | -68.7 | 71.2 | -20.6 | 57.1 | 81.4 |
Income taxes payable and receivable | 0.7 | -25.6 | -27.1 | 55.2 | 87.4 | -53.7 | 46.9 | -3.0 |
Accrued liabilities and other | -17.7 | 31.0 | -6.2 | -40.6 | -42.7 | -39.9 | -90.0 | 0.9 |
Net cash provided by operating activities | 92.1 | 149.8 | 139.3 | 203.5 | 217.9 | 127.2 | 666.0 | 722.7 |
|
INVESTING ACTIVITIES | | | | | | | | |
Capital expenditures | -73.3 | -85.6 | -138.8 | -104.4 | -108.5 | -172.1 | -207.6 | -223.6 |
Acquisition of business | | | -3.0 | | | -48.1 | -118.2 | -380.8 |
Dispositions of businesses, net of cash disposed | -1.4 | 247.6 | 50.6 | | | | | |
Proceeds related to life insurance policies | 0.2 | 100.0 | | | | | | |
Net cash (used in) provided by investing activities | -55.3 | 305.0 | -25.8 | -7.4 | 24.7 | -200.6 | -322.3 | -577.2 |
|
FINANCING ACTIVITIES | | | | | | | | |
Proceeds from issuance of long-term debt | 451.1 | | | 544.5 | | 1,164.0 | | 400.0 |
Proceeds from credit facility borrowings | 1,168.0 | 633.0 | 1,250.8 | 1,246.1 | 1,437.0 | 850.0 | | |
Payments on credit facility borrowings | -1,136.0 | -675.0 | -1,267.8 | -1,403.1 | -1,406.0 | -665.0 | | |
Debt issuance costs | -8.2 | | -0.3 | -10.6 | -5.9 | -37.5 | | -13.7 |
Dividends paid | | -2.1 | -8.5 | -23.9 | -39.2 | -173.0 | -212.6 | -203.1 |
Net cash used in financing activities | -75.3 | -329.3 | -289.4 | -77.2 | -294.3 | 19.9 | -444.8 | -605.1 |
Effect of exchange rate on cash, cash equivalents and restricted cash | 1.2 | 8.3 | -3.9 | | | | | |
|
Supplemental cash flow disclosures: | | | | | | | | |